摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(-)-(R)-4-azidobutane-1,3-diol | 872104-77-3

中文名称
——
中文别名
——
英文名称
(-)-(R)-4-azidobutane-1,3-diol
英文别名
(3R)-4-azidobutane-1,3-diol
(-)-(R)-4-azidobutane-1,3-diol化学式
CAS
872104-77-3
化学式
C4H9N3O2
mdl
——
分子量
131.134
InChiKey
MKOAQYUZUSTOFJ-SCSAIBSYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    9
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    54.8
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    苯甲酮二甲基缩酮(-)-(R)-4-azidobutane-1,3-diol对甲苯磺酸sodium sulfate 作用下, 以 四氢呋喃 为溶剂, 反应 7.0h, 以71%的产率得到(+)-(4R)-4-azidomethyl-2,2-diphenyl-1,3-dioxane
    参考文献:
    名称:
    Structure–affinity relationship studies of non-competitive NMDA receptor antagonists derived from dexoxadrol and etoxadrol
    摘要:
    The synthesis and NMDA receptor affinity of ring and side-chain homologues of etoxadrol and dexoxadrol are described. For the regioselective synthesis of etoxadrol homologues, the regioisomeric 4-azidobutanediols (+/-)-9 and (+/-)-14 were employed. A synthesis of the enantiomerically pure azidobutanediols (S)-, (R)-9 and (S)-, (R)-14 was developed and the homochiral building blocks were used for the synthesis of enantiomerically pure etoxadrol and dexoxadrol homologues. The affinity of the racemic and enantiomerically pure primary amines toward the phencyclidine binding site of the NMDA receptor was investigated in receptor binding studies with tritium labeled [H-3]-(+)-MK-801 as radioligand. Benzaldehyde derivatives (+/-)-12a, (+/-)-13a, and (+/-)-16a bearing a proton at the acetalic position do not interact significantly with the NMDA receptor. An enantioselective NMDA receptor binding was observed for the trans-configured 2-(2-ethyl-2-phenyl-1,3-dioxolan-4-yl)ethanamine 13b, the (2-ethyl-2-phenyl-1,3-dioxan-4-yl)methanamine 16b, and the (2,2-diphenyl-1,3-dioxan-4-yl)methanamine 16c. The NMDA receptor affinity of these compounds resides almost exclusively in the (S)-configured enantiomers (2S,4S)-13b, (2S,4S)-16b, and (4S)-16c. The lowest K-i-value in this series was found for the (2S,4S)-configured 1,3-dioxolane (2S,4S)-13b (K-i = 69 nM), which is in the range of the Ki-value of the lead compounds etoxadrol and dexoxadrol, indicating that the 2-aminoethyl and the piperidin-2-yl substituents lead to similar NMDA receptor interactions. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2005.07.030
  • 作为产物:
    描述:
    (+)-(2R,4R)-4-(azidomethyl)-2-tert-butyl-1,3-dioxane 在 Amberlyst 15 acidic form 作用下, 以 甲醇 为溶剂, 反应 4.0h, 以92%的产率得到(-)-(R)-4-azidobutane-1,3-diol
    参考文献:
    名称:
    Structure–affinity relationship studies of non-competitive NMDA receptor antagonists derived from dexoxadrol and etoxadrol
    摘要:
    The synthesis and NMDA receptor affinity of ring and side-chain homologues of etoxadrol and dexoxadrol are described. For the regioselective synthesis of etoxadrol homologues, the regioisomeric 4-azidobutanediols (+/-)-9 and (+/-)-14 were employed. A synthesis of the enantiomerically pure azidobutanediols (S)-, (R)-9 and (S)-, (R)-14 was developed and the homochiral building blocks were used for the synthesis of enantiomerically pure etoxadrol and dexoxadrol homologues. The affinity of the racemic and enantiomerically pure primary amines toward the phencyclidine binding site of the NMDA receptor was investigated in receptor binding studies with tritium labeled [H-3]-(+)-MK-801 as radioligand. Benzaldehyde derivatives (+/-)-12a, (+/-)-13a, and (+/-)-16a bearing a proton at the acetalic position do not interact significantly with the NMDA receptor. An enantioselective NMDA receptor binding was observed for the trans-configured 2-(2-ethyl-2-phenyl-1,3-dioxolan-4-yl)ethanamine 13b, the (2-ethyl-2-phenyl-1,3-dioxan-4-yl)methanamine 16b, and the (2,2-diphenyl-1,3-dioxan-4-yl)methanamine 16c. The NMDA receptor affinity of these compounds resides almost exclusively in the (S)-configured enantiomers (2S,4S)-13b, (2S,4S)-16b, and (4S)-16c. The lowest K-i-value in this series was found for the (2S,4S)-configured 1,3-dioxolane (2S,4S)-13b (K-i = 69 nM), which is in the range of the Ki-value of the lead compounds etoxadrol and dexoxadrol, indicating that the 2-aminoethyl and the piperidin-2-yl substituents lead to similar NMDA receptor interactions. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2005.07.030
点击查看最新优质反应信息

文献信息

  • A Total Synthesis of Hydroxylysine in Protected Form and Investigations of the Reductive Opening of <i>p</i>-Methoxybenzylidene Acetals
    作者:Tomas Gustafsson、Magnus Schou、Fredrik Almqvist、Jan Kihlberg
    DOI:10.1021/jo049136w
    日期:2004.12.1
    A synthesis of (2S,5R)-5-hydoxylysine, based on (R)-malic acid and Williams glycine template as chiral precursors, has been developed. This afforded hydroxylysine, suitably protected for direct use in peptide synthesis, in 32% yield over the 13-step sequence. Regioselective reductive opening of a p-methoxybenzylidene acetal and alkylation of the Williams glycine template were key steps in the synthetic
    (2的合成小号,5 - [R)-5- hydoxylysine,基于([R )-苹果酸和Williams甘酸模板作为手性前体,已经研制成功。这样得到的羟基赖酸经过适当保护,可直接用于肽合成,在13步序列中的收率为32%。对甲氧基亚苄基乙缩醛的区域选择性还原打开和威廉姆斯甘酸模板的烷基化是合成序列中的关键步骤。出人意料的是,p开口处的区域选择性与预期相比,将-甲氧基亚苄基缩醛逆转。发现这是由于在还原开口中用作亲电子试剂的三烷基甲硅烷化物与相邻的叠氮化物官能团的螯合。还发现在反应中形成了等量的三烷基甲硅烷氢化物,这一发现导致对用氰基硼氢化钠作为还原剂的对-甲氧基亚苄基乙缩醛的还原开口的进一步机理研究。
查看更多